| Dec'19 | Dec'18 | |||||
|---|---|---|---|---|---|---|
Operating expenses | ||||||
Research and development | ||||||
37,488 | 19,673 | |||||
General and administrative | ||||||
13,894 | 6,780 | |||||
Total operating expenses | ||||||
51,382 | 26,453 | |||||
Loss from operations | ||||||
-51,382 | -26,453 | |||||
Interest income, net | ||||||
3,885 | 2,202 | |||||
Loss before income taxes | ||||||
-47,497 | -24,251 | |||||
Income taxes | ||||||
102 | - | |||||
Net loss | ||||||
-47,599 | -24,251 | |||||
Accretion of redeemable convertible preferred stock to redemption value | ||||||
49,900 | 37,298 | |||||
Net loss attributable to common stockholders | ||||||
-97,499 | -61,549 | |||||
Per share information | ||||||
Net loss per share of common stock, basic and diluted | ||||||
-4.62 | -98.53 | |||||
Weighted average shares outstanding, basic and diluted | ||||||
21,104 | 624 | |||||